(Q42989590)
Statements
1 reference
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. (English)
1 reference
Tami Pilot-Matias
1 reference
Kris V Kowdley
1 reference
Eric Lawitz
1 reference
Daniel E Cohen
1 reference
Thomas Podsadecki
1 reference
Sara Siggelkow
1 reference
Lois Larsen
1 reference
Rajeev Menon
1 reference
Gennadiy Koev
1 reference
Rakesh Tripathi
1 reference
Barry Bernstein
1 reference
22 February 2013
1 reference
1 reference
Identifiers
1 reference